2/4
04:30 pm
olma
Olema Oncology to Participate in Upcoming Investor Conferences
Medium
Report
Olema Oncology to Participate in Upcoming Investor Conferences
2/3
04:30 pm
olma
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/31
07:03 pm
olma
Olema CFO Exit Puts Focus On Palazestrant Plans And Cash Discipline [Yahoo! Finance]
Low
Report
Olema CFO Exit Puts Focus On Palazestrant Plans And Cash Discipline [Yahoo! Finance]
1/30
07:12 pm
olma
LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA) [Yahoo! Finance]
Low
Report
LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA) [Yahoo! Finance]
1/30
04:01 pm
olma
Olema Oncology Announces Departure of Chief Operating and Financial Officer
Low
Report
Olema Oncology Announces Departure of Chief Operating and Financial Officer
1/13
08:56 pm
olma
JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]
Medium
Report
JPM26: Roche's rejuvenation strategy for the oncology and haematology portfolio [Yahoo! Finance]
1/9
11:46 am
olma
Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]
Medium
Report
Olema Insider Sells $8 Million in Shares After 300% Stock Surge [Yahoo! Finance]
1/9
06:10 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
11/10/2025
07:00 am
olma
olema pharmaceuticals, inc.
MISS
Report
6.1%
olema pharmaceuticals, inc.
8/11/2025
04:01 pm
olma
olema pharmaceuticals, inc.
MISS
Report
8.5%
olema pharmaceuticals, inc.
5/13/2025
04:01 pm
olma
olema pharmaceuticals, inc.
BEAT
Report
-3.8%
olema pharmaceuticals, inc.
3/18/2025
04:01 pm
olma
olema pharmaceuticals, inc.
BEAT
Report
-0.7%
olema pharmaceuticals, inc.
2/4
09:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Myles David C.
Low
Report
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Myles David C.
2/4
09:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Zojwalla Naseem
Low
Report
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Zojwalla Naseem
2/4
09:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Mitchell Shawnte
Low
Report
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Mitchell Shawnte
2/4
09:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Bohen Sean
Low
Report
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Bohen Sean
1/30
04:07 pm
olma
Form 8-K Olema Pharmaceuticals, For: Jan 27
Low
Report
Form 8-K Olema Pharmaceuticals, For: Jan 27
1/21
09:00 pm
olma
Form 4 Olema Pharmaceuticals, For: Jan 20 Filed by: Harmon Cyrus
Low
Report
Form 4 Olema Pharmaceuticals, For: Jan 20 Filed by: Harmon Cyrus
1/20
04:14 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Harmon Cyrus
Low
Report
Form 144 Olema Pharmaceuticals, Filed by: Harmon Cyrus
1/16
09:00 pm
olma
Form 4 Olema Pharmaceuticals, For: Jan 14 Filed by: Harmon Cyrus
Low
Report
Form 4 Olema Pharmaceuticals, For: Jan 14 Filed by: Harmon Cyrus
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register